Results 201 to 210 of about 279,658 (282)

Causal connectivity maps derived from single-pulse interleaved TMS/fMRI. [PDF]

Sci Rep
Bossus L, Dickson J, Blaine C, Khalilkhani H, Khan A, Oathes DJ.   +5 more
europepmc   +1 more source

Conceptualizing age‐appropriate social media to support children's digital futures

British Journal of Developmental Psychology, EarlyView.
Abstract Is there really a ‘right age’ for social media? As governments rush to regulate children's digital lives, age‐based bans and ‘age‐appropriate’ design regulations are gaining international momentum. However, these are often based on theoretically dated ‘ages and stages’ models and blunt age thresholds.
Sonia Livingstone, Kim R. Sylwander
wiley   +1 more source

Tau‐targeting active immunotherapy slows progression and reduces pathology in mouse models of tauopathy

Brain Pathology, EarlyView.
The efficacy of the novel anti‐tau active immunotherapy, p5555kb, was tested using two mouse models of tau pathology. p5555kb inoculation increased the survival rate and reduced tau pathology in tau‐overexpressing P301L mice and decreased tau seeding in the brains of C57BL/6 mice injected with human‐purified Alzheimer's disease tau.
Christopher M. Brown, Jeanne K. Brooks, Louise Kelly, Madeline M. Vroom, Matthew Longo, Jean‐Cosme Dodart, Roxana Carare, Justin D. Boyd   +7 more
wiley   +1 more source

The role of the amygdala in depression: a bibliometric analysis (2015-2024). [PDF]

Front Psychiatry
Li Y, Yang D, Cao M, Dong L, Jin L, Gao S.   +5 more
europepmc   +1 more source

Frontotemporal dementia: Clinical aspects, genetics, and neuropathology of a family with a C9ORF72 expansion in Argentina

Brain Pathology, EarlyView.
Immunohistochemistry for TDP‐43: (A)—Dentate gyrus; (B)—Temporal lobe. Abstract Frontotemporal dementia (FTD) is the second most common cause of early‐onset dementia, typically manifesting before the age of 65, with a mean onset at 58 years. FTD may encompass a spectrum of neurodegenerative disorders resulting from frontotemporal lobar degeneration ...
Karen Daniela Román, Carolina Agata Ardohain, Ezequiel I. Surace, Mónica Beatriz Mezmezian, Alejandro Levy, Alice Baez Lovera, Carlos Turizo, Marcos G. Sorbara, María M. Esnaola y Rojas, Gastón H. Graviotto, Gustavo Sevlever, Ricardo F. Allegri, Cecilia M. Serrano, Nahuel Magrath Guimet   +13 more
wiley   +1 more source

Amygdala functional connectivity and response to aerobic exercise in subthreshold depression-an exploratory fMRI study. [PDF]

BMC Psychiatry
Huang L, Zhang W, Zhang J, Li Q, Shen W, Zhang H, Yin X, Zhou J, Ding Q.   +8 more
europepmc   +1 more source

The Australia story: Current status and future challenges for the clinical applications of psychedelics

British Journal of Pharmacology, EarlyView.
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt, Peter Hunt, Anne Katrin Schlag, Paul Fitzgerald   +3 more
wiley   +1 more source

Specific atrophy patterns distinguish tau and TDP-43 pathology: a longitudinal MRI ante-mortem study. [PDF]

Acta Neuropathol Commun
Salman Y, Goloubeva J, Huyghe L, Quenon L, Tomé SO, Hanseeuw B, Alzheimer’s Disease Neuroimaging Initiative.   +6 more
europepmc   +1 more source